Bioavailability Assessment
Bioavailability Assessment is a pharmacokinetic evaluation that quantifies, typically by noncompartmental analysis of concentration–time data, the rate and extent to which an active drug ingredient or moiety is absorbed from a dosage form and becomes available at the site of action or in the systemic circulation.
1.6K
Publications
90K
Citations
6.5K
Authors
1.6K
Institutions
Publications per year
2017–2026
195
1.6K
Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah et al. · Pharmaceutical Research · 1995 · 5.3K citations · Full text
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Thomas Walle, Faye Hsieh, Mark H. DeLegge et al. · Drug Metabolism and Disposition · 2004 · 1.8K citations
Yvonne C. Martin · Journal of Medicinal Chemistry · 2005 · 994 citations
Pharmacy, Chemistry, Pharmacology +16
1–5 of 1.6K
6.5K
16
h-index
13
h-index
9
h-index
9
h-index
9
h-index
1–5 of 6.5K
1.6K
United States Food and Drug Administration
Silver Spring, United States
18 h-index
54 publications
4.6K citations
University of California, San Francisco
San Francisco, United States
16 h-index
60 publications
3K citations
Bristol-Myers Squibb (United States)
New York, United States
16 h-index
88 publications
4.9K citations
Center for Drug Evaluation and Research
Silver Spring, United States
16 h-index
66 publications
14.5K citations
Novartis (Switzerland)
Basel, Switzerland
15 h-index
50 publications
3.2K citations
University at Buffalo, State University of New York
Buffalo, United States
14 h-index
38 publications
1.6K citations
Goethe University Frankfurt
Frankfurt am Main, Germany
13 h-index
28 publications
1.3K citations

University of Maryland, Baltimore
Baltimore, United States
13 h-index
27 publications
2.8K citations
1–8 of 1.6K
CPT · 57 publications · 4.1K citations
36
h-index
Repository · 141 publications · 5K citations
34
h-index
BJCP · 54 publications · 4.1K citations
32
h-index
78 publications · 4K citations
31
h-index
50 publications · 3K citations
30
h-index
1–5